CD5L Deficiency Protects Mice Against Bleomycin-Induced Pulmonary Fibrosis

CD5L Deficiency Protects Mice Against Bleomycin-Induced Pulmonary Fibrosis

Background: Pulmonary fibrosis (PF), the most common clinical type of irreversible interstitial lung disease with one of the worse prognoses, has a largely unknown molecular mechanisms that underlies its progression. CD5 molecule-like (CD5L) functions in an indispensable role during inflammatory res...

Full description

Bibliographic Details
Main Authors: Yang Guo, Mengyan Zhu, Ruling Shen
Format: Article
Language:English
Published: IMR Press 2023-09-01
Series:Frontiers in Bioscience-Landmark
Subjects:
cd5l
pulmonary fibrosis
macrophage
Online Access:https://www.imrpress.com/journal/FBL/28/9/10.31083/j.fbl2809209

Internet

https://www.imrpress.com/journal/FBL/28/9/10.31083/j.fbl2809209

Similar Items